Clinical Trial Update: Rituximab-pvvr and Abatacept vs Rituximab-pvvr Alone in New Onset Type 1 Diabetes [Phase 2]

View source ↗

Summary

A Phase 2 trial comparing Rituximab-pvvr plus Abatacept against Rituximab-pvvr alone in new-onset Type 1 Diabetes is currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 1 Diabetes Mellitus

Drugs mentioned

• Abatacept (abatacept)
• Rituximab-pvvr (rituximab-pvvr)

Snippet

Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | Conditions: Type 1 Diabetes Mellitus | Phase 2 | Status: ACTIVE_NOT_RECRUITING